New Products | 合法醫療器材資訊網

AscontinuousimprovementofreagentsispartofStago'sstrategy,wearepleasedtoannounceournewPTreagentfromStago:STA-NeoPTimal.Readmore.

Stago applies its expertise in Haemostasis to bring a new platelet aggregation system solution to the market (1)[1]

Disorders of primary haemostasis caused by platelet or von Willebrand factor defects or deficiencies are relatively rare. Although specialists understand the pathologies well, most medical facilities lack the complex diagnostic equipment required to manage these patients; therefore, patients are typically referred to speciality care centres for diagnosis and treatment.